Global Gene Therapy Market
Pharmaceuticals

From Insight to Impact: Strategic Growth Mapping in the Gene Therapy Market

Discover trends, market shifts, and competitive outlooks for the gene therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Gene Therapy Market Size from 2025 to 2034?

In the past few years, there has been a remarkable growth in the size of the gene therapy market. It is projected to escalate from $12.52 billion in 2024 to $16.36 billion in 2025, marking a compound annual growth rate (CAGR) of 30.7%. The noteworthy growth during the historic period is credited to factors such as increased pharmaceutical R&D spending, proliferation of public-private collaborations, government funding, and a surge in instances of spinal muscular atrophy.

Accelerated expansion is anticipated in the gene therapy market size over the next few years. With a compound annual growth rate (CAGR) of 17.8%, it is projected to reach $31.48 billion by 2029. The projected growth during this period is largely due to the escalating number of cancer cases, the aging population swell, rising expenditure in pharmaceutical research and development, and an intensifying focus on gene therapy. Key trends for the forecast period encompass procuring regulatory approvals to enhance business procedures, fortifying business activities via strategic collaborations and partnerships, broadening business prowess through tactical acquisitions, and bolstering operational capacities through business expansions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What are the Fundamental Drivers and Innovations Shaping the Gene Therapy Market?

The growing incidence of cancer and other targeted diseases is necessitating efficient treatments, thereby fueling the gene therapy market’s expansion. The surge in global cancer rates is expected to significantly boost the gene therapy market over the projection period. For example, the American Cancer Society predicts that in January 2022, there may be around 1.9 million new cancer cases and 609,360 cancer-related deaths in the US, with approximately 1,670 deaths occurring each day. Lung, prostate, bowel, and female breast cancer are globally the four most common cancer types, comprising 43 percent of all newly diagnosed cancer cases. Hence, the global increase in cancer cases is presumed to drive demand for the gene therapy market in the coming years. Gene therapy, one of the most efficient cancer treatments, involves introducing new genes into a cancer cell or its surrounding tissue to trigger cell death or slow cancer growth.

How Is the Gene Therapy Market Segmented?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Regions Are Driving the Next Phase of the Gene Therapy Market Growth?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Gene Therapy Market?

The gene therapy market is slowly but surely embracing machine learning and artificial intelligence. AI, which replicates human intelligence in machines, and machine learning, a component of AI, are proving to be beneficial in the deep analysis of significant data. These technologies are providing critical insights into tumor-immune cell interactions and offer a more precise assessment of tissue samples, a topic often subject to contention among various evaluators. For example, in May 2023, FORMsightAI, a fresh AI-driven solution for forecasting and enhancing cell and gene therapy constructs’ production outputs was introduced by US-based Form Bio. Leveraging advanced AI models, Form Bio’s foundational platform, and experts in computational life science, FORMsightAI is a comprehensive solution. It addresses key challenges in cell and gene therapy development like construct truncations and manufacturing contaminations, which often lead to low manufacturing yields, delayed market entry, and safety concerns in therapeutics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Is the Gene Therapy Market Defined and What Are Its Core Parameters?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model